Brief: ExpreS2ion, Serum Institute Of India Enter Definitive Licensing Agreement For Malaria Vaccines
12/11/2025 14:59
Nov 12 (Reuters) - ExpreS2ion Biotech Holding AB EXPRS2.ST: EXPRES2ION AND SERUM INSTITUTE OF INDIA ENTER DEFINITIVE LICENSING AGREEMENT FOR MALARIA VACCINES Source text: ID:nWkr9XvNcB Further company coverage: EXPRS2.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations